Histone-Lysine N-Methyltransferase SMYD3 (SMYD3) protein (GST tag)
-
- Target
- Histone-Lysine N-Methyltransferase SMYD3 (SMYD3)
- Protein-Typ
- Recombinant
- Spezies
- Human
- Quelle
- Baculovirus infected Insect Cells
- Aufreinigungstag / Konjugat
- GST tag
- Verwendungszweck
- Recombinant Human SMYD3/ZMYND1 Protein (GST Tag)
- Sequenz
- Lys 35-Ser 369
- Produktmerkmale
- A DNA sequence encoding the human SMYD3 isoform 2 (NP_073580.1) (Lys 35-Ser 369) was fused with the GST tag at the N-terminus.
- Reinheit
- > 88 % as determined by reducing SDS-PAGE.
- Endotoxin-Niveau
- < 1.0 EU per μg as determined by the LAL method.
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Please refer to the printed manual for detailed information.
- Buffer
- Lyophilized from sterile 20 mM Tris, 150 mM NaCl, 0.5 mM DTT, 0.5 mM GSH, pH 8.0
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
-
- Target
- Histone-Lysine N-Methyltransferase SMYD3 (SMYD3)
- Andere Bezeichnung
- SMYD3/ZMYND1
- Hintergrund
-
Background: SET and MYND domain-containing protein 3, also known as Zinc finger MYND domain-containing protein 1, SMYD3, and ZMYND, is a member of the histone-lysine methyltransferase family. SMYD3 contains one MYND-type zinc finger and one SET domain. SMYD3 is a histone H3 lysine-4-specific methyltransferase. It is expressed in skeletal muscles and testis. It is overexpressed in a majority of colorectal carcinoma (CRC) and hepatocellular carcinoma (HCC). SMYD3 plays an important role in transcriptional regulation in human carcinogenesis. It activates the transcription of a set of downstream genes. Of these downstream genes, there are several oncogenes and genes associated with cell adhesion (including those of N-Myc, CrkL, Wnt10b, L-selectin, CD31 and galectin-4), which have been shown to have effects on cell viability, adhesion, migration and metastasis. Increased SMYD3 expression is essential for the proliferation of breast cancer cells. SMYD3 may be a promising new target of therapeutic intervention for the treatment of cancers or other pathological processes associated with cell adhesion and migration.
Synonym: bA74P14.1;KMT3E;ZMYND1;ZNFN3A1
- Molekulargewicht
- 656 kDa
- NCBI Accession
- NP_073580
-